157 related articles for article (PubMed ID: 32063918)
21. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer.
Xu L; Pan J; Ding Y; Pan H
Front Genet; 2020; 11():522383. PubMed ID: 33193606
[TBL] [Abstract][Full Text] [Related]
22. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
23. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.
Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y
Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203
[TBL] [Abstract][Full Text] [Related]
24. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
25. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma.
Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T
Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
Huang ZG; He RQ; Mo ZN
Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
[TBL] [Abstract][Full Text] [Related]
27. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.
Liang Y; Song J; He D; Xia Y; Wu Y; Yin X; Liu J
J Cell Physiol; 2019 Sep; 234(9):15836-15846. PubMed ID: 30740675
[TBL] [Abstract][Full Text] [Related]
28. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
29. Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events.
Wu HY; Wei Y; Liu LM; Chen ZB; Hu QP; Pan SL
Oncol Lett; 2019 Nov; 18(5):4677-4690. PubMed ID: 31611977
[TBL] [Abstract][Full Text] [Related]
30. A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma.
Gao L; Xie ZC; Pang JS; Li TT; Chen G
Aging (Albany NY); 2019 Jan; 11(1):263-283. PubMed ID: 30640723
[TBL] [Abstract][Full Text] [Related]
31. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J
Front Genet; 2019; 10():1380. PubMed ID: 32117422
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
33. Alternative splicing events are prognostic in hepatocellular carcinoma.
Chen QF; Li W; Wu P; Shen L; Huang ZL
Aging (Albany NY); 2019 Jul; 11(13):4720-4735. PubMed ID: 31301224
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer.
Chen P; He J; Ye H; Jiang S; Li Y; Li X; Wan J
Front Genet; 2020; 11():456. PubMed ID: 32547595
[TBL] [Abstract][Full Text] [Related]
36. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
37. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
38. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
39. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
40. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
